AbbVie seeks FDA approval for TrenibotE to treat glabellar lines
AbbVie is positioning TrenibotE, a serotype E botulinum neurotoxin, as an option for patients exploring aesthetic neurotoxin treatments for the first time
Granite Bio secures $100m funding to advance autoimmune disease treatments
Guardant Health announces strategic collaboration with Pfizer
Veraxa Biotech to go public via $1.64bn SPAC deal with Voyager Acquisition
Tempus partners with AstraZeneca and Pathos for oncology AI model
Repertoire, Genentech partner to develop T cell-targeted therapies
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry